1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Global Market Study on Insulin Delivery Devices: Asia to Witness Highest Growth by 2020

Diabetes is a disease characterized by high blood sugar levels. It is caused by the improper functioning of the pancreas that secretes insulin. Insulin is a hormone that maintains blood sugar levels in the body and helps in the proper functioning of all cellular and physiological activities. Diabetes is more common in the aged population; however, incidence of diabetes is also increasing in children and adults. To overcome this problem, insulin delivery devices, such as insulin pens, pumps, syringes, and jet injectors, play a vital role in maintaining insulin levels in the body. Insulin pens, syringes, and pumps are devices that facilitate the delivery of insulin just under the skin through a needle.

Insulin syringes are designed for self-administration of doses and have many user-friendly features. For instance, these devices have short needles that are less painful for the patient. Insulin pen comprises insulin cartridge, dial and a needle. Insulin pen devices are used with disposable needles for the delivery of insulin doses. The compact design of these devices allows discreet administration of insulin. Insulin pens are of two types: prefilled and reusable. A prefilled pen is discarded once the contents of an insulin cartridge are administered, whereas a reusable pen contains replaceable insulin cartridges which are loaded and removed from the pen.

Insulin pump is composed of a pump, a disposable reservoir to hold the insulin, and a disposable infusion set, including cannula for subcutaneous insertion of doses. An insulin pump can be worn externally and clipped to wearer’s belt. Insulin jet injectors inject insulin without the use of any needle. Insulin jets are composed of three parts: a disposable injector nozzle, the delivery device shaped like a pen, and a disposable insulin vial adapter.

Globally, the increasing prevalence of diabetes and obesity are some major drivers for the growth of the market. In addition, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting the growth of the global insulin delivery devices market.

However, risk and complications associated with the delivery of insulin and high cost of insulin analog hamper the growth of the market. Artificial pancreas and home infusion therapy are some of the major trends of global insulin delivery devices market.

Under geographic analysis, North America dominates the global insulin delivery devices market due to increasing prevalence of diabetes and rising number of overweight and obese people. The U.S. represents the largest market for insulin delivery devices followed by Canada in North America. Germany, France, the U.K., Italy and Spain holds major share of insulin delivery devices market in Europe. However, Asia is the fastest growing region in the global insulin delivery devices market due to rising aging population. In addition, several government initiatives are increasing awareness about diabetes treatment which would increase the demand for insulin delivery devices in the region.

The global insulin delivery devices market report provides in-depth analysis and estimation of the insulin delivery devices market from 2014 to 2020, considering 2014 as the base year for calculation. Additionally, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the global insulin delivery devices market report.

Some of the major players operating in the market are Abbott Laboratories, Novo Nordisk A/S, Eli Lilly and Company, Medtronic, Inc., Sanofi, Becton, Dickinson and Company, and F. Hoffmann-La Roche, Ltd. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.

Table Of Contents

Global Market Study on Insulin Delivery Devices: Asia to Witness Highest Growth by 2020
Chapter 1 Preface

1.1 Report Description

1.2 Report Methodology

1.3 Assumptions

Chapter 2 Market Synopsis

Chapter 3 Porter's Five Forces Analysis

3.1 Bargaining Power of Suppliers

3.2 Bargaining Power of Buyers

3.3 Threat of New Entrants

3.4 Threat of Substitutes

3.5 Intensity of Rivalry

Chapter 4 Industry Overview

4.1 Market Definition

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes enhance the market growth

4.2.2 Globally rising obesity is increasing the prevalence of diabetes

4.2.3 Advanced features of insulin delivery devices attract end users

4.2.4 Rising awareness among people about diabetes care

4.3 Impact Analysis of Market Drivers

4.4 Market Restraints

4.4.1 Risk and complications associated with delivery of insulin

4.4.2 High cost of insulin analog impedes the market growth

4.5 Impact Analysis of Market Restraints

4.6 Market Trends

4.6.1 Artificial pancreas is gaining popularity in the insulin delivery devices market

4.6.2 Home infusion therapy is gaining importance in treatment of diabetes

Chapter 5 Global Market Size and Forecast

Chapter 6 Market Size and Forecast by Device

6.1 Insulin Syringes

6.2 Insulin Pens

6.3 Insulin Pumps

6.4 Insulin Jet Injectors

Chapter 7 Market Size and Forecast by Geography

7.1 North America

7.1.1 Scenario in the U.S.

7.1.2 Scenario in Canada

7.2 Europe

7.2.1 Scenario in Germany

7.2.2 Scenario in France

7.2.3 Scenario in the U.K.

7.2.4 Scenario in Italy

7.2.5 Scenario in Spain

7.3 Asia

7.3.1 Scenario in Japan

7.3.2 Scenario in China

7.3.3 Scenario in India

7.4 Latin America

7.4.1 Scenario in Brazil

Chapter 8 Competitive Scenario

8.1 Market Share Analysis

8.2 Competitive Benchmarking

Chapter 9 Company Profiles

9.1 Abbott Laboratories

9.1.1 Company Overview

9.1.2 Products and Services

9.1.3 Financial Performance

9.1.4 Recent Developments

9.2 Novo Nordisk A/S

9.2.1 Company Overview

9.2.2 Products and Services

9.2.3 Financial Performance

9.2.4 Recent Developments

9.3 Eli Lilly and Company

9.3.1 Company Overview

9.3.2 Products and Services

9.3.3 Financial Performance

9.3.4 Recent Developments

9.4 Medtronic, Inc.

9.4.1 Company Overview

9.4.2 Products and Services

9.4.3 Financial Performance

9.4.4 Recent Developments

9.5 Sanofi

9.5.1 Company Overview

9.5.2 Products and Services

9.5.3 Financial Performance

9.5.4 Recent Developments

9.6 Becton, Dickinson and Company

9.6.1 Company Overview

9.6.2 Products and Services

9.6.3 Financial Performance

9.6.4 Recent Developments

9.7 F. Hoffmann-La Roche, Ltd.

9.7.1 Company Overview

9.7.2 Products and Services

9.7.3 Financial Performance

9.7.4 Recent Developments

9.8 Insulet Corporation

9.8.1 Company Overview

9.8.2 Products and Services

9.8.3 Financial Performance

9.8.4 Recent Developments

9.9 Ypsomed Holding AG

9.9.1 Company Overview

9.9.2 Products and Services

9.9.3 Financial Performance

9.9.4 Recent Developments

9.10 Animas Corporation

9.10.1 Company Overview

9.10.2 Products and Services

9.10.3 Financial Performance

9.10.4 Recent Developments

9.11 B. Braun Melsungen AG

9.11.1 Company Overview

9.11.2 Products and Services

9.11.3 Financial Performance

9.11.4 Recent Developments

List of Tables

TABLE 1 Market Snapshot: Global market for insulin delivery devices (2014 and 2020)

TABLE 2 Drivers of insulin delivery devices market: Impact analysis

TABLE 3 Restraints for insulin delivery devices market: Impact analysis

TABLE 4 Global market for insulin delivery devices, by geography, 2010 - 2013 (USD million)

TABLE 5 Global market for insulin delivery devices, by geography, 2014 - 2020 (USD million)

TABLE 6 Global market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 7 Global market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 8 Global market for insulin syringes, by geography, 2010 - 2013 (USD million)

TABLE 9 Global market for insulin syringes, by geography, 2014 - 2020 (USD million)

TABLE 10 Global market for insulin pen, by geography, 2010 - 2013 (USD million)

TABLE 11 Global market for insulin pen, by geography, 2014 - 2020 (USD million)

TABLE 12 Global market for insulin pumps, by geography, 2010 - 2013 (USD million)

TABLE 13 Global market for insulin pumps, by geography, 2014 - 2020 (USD million)

TABLE 14 Global market for insulin jet injectors, by geography, 2010 - 2013 (USD million)

TABLE 15 Global market for insulin jet injectors, by geography, 2014 - 2020 (USD million)

TABLE 16 The North American market for insulin delivery devices, by country, 2010 - 2013 (USD million)

TABLE 17 The North American market for insulin delivery devices, by country, 2014 - 2020 (USD million)

TABLE 18 The North American market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 19 The North American market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 20 The U.S. market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 21 The U.S. market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 22 Canadian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 23 Canadian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 24 The European market for insulin delivery devices, by country, 2010 - 2013 (USD million)

TABLE 25 The European market for insulin delivery devices, by country, 2014 - 2020 (USD million)

TABLE 26 The European market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 27 The European market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 28 German market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 29 German market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 30 French market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 31 French market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 32 The U.K. market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 33 The U.K. market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 34 Italian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 35 Italian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 36 Spanish market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 37 Spanish market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 38 The Asian market for insulin delivery devices, by country, 2010 - 2013 (USD million)

TABLE 39 The Asian market for insulin delivery devices, by country, 2014 - 2020 (USD million)

TABLE 40 The Asian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 41 The Asian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 42 Japanese market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 43 Japanese market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 44 Chinese market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 45 Chinese market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 46 Indian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 47 Indian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 48 The Latin American market for insulin delivery devices, by country, 2010 - 2013 (USD million)

TABLE 49 The Latin American market for insulin delivery devices, by country, 2014 - 2020 (USD million)

TABLE 50 The Latin American market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 51 The Latin American market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 52 Brazilian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 53 Brazilian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 54 Abbott's major product categories

TABLE 55 Novo Nordisk's product segments

TABLE 56 Lilly's product segments

TABLE 57 Medtronic's product segments

TABLE 58 Sanofi's major product categories

TABLE 59 BD's product segments

TABLE 60 Roche's product categories

TABLE 61 Insulet's product category

TABLE 62 Ypsomed's product categories

TABLE 63 Animas's major product categories

TABLE 64 B. Braun product divisions

List of Figures

FIG. 1 Insulin delivery devices market: Porter\'s five forces analysis

FIG. 2 Major insulin delivery devices

FIG. 3 Emerging insulin delivery technologies

FIG. 4 Number of people with diabetes mellitus (20 - 79 years) in major countries, 2010 and 2030 (million)

FIG. 5 Prevalence of overweight and obese males aged 30 and above, 2005 and 2015 (%)

FIG. 6 Prevalence of overweight and obese females aged 30 and above, 2005 and 2015 (%)

FIG. 7 Global insulin delivery devices market share, by region, by value, 2013

FIG. 8 Global insulin delivery devices market share, by device, by value, 2013

FIG. 9 Global insulin syringes market share, by region, by value, 2013

FIG. 10 Global insulin pens market share, by region, by value, 2013

FIG. 11 Global insulin pumps market share, by region, by value, 2013

FIG. 12 Global insulin jet injectors market share, by region, by value, 2013

FIG. 13 The North American insulin delivery devices market share, by country, by value, 2013

FIG. 14 The North American insulin delivery devices market share, by device, by value, 2013

FIG. 15 The U.S. insulin delivery devices market share, by device, by value, 2013

FIG. 16 Prevalence of diabetes mellitus in people aged 20 - 79, 2010 and 2030 (thousand)

FIG. 17 Canadian insulin delivery devices market share, by device, by value, 2013

FIG. 18 The European insulin delivery devices market share, by country, by value, 2013

FIG. 19 The European insulin delivery devices market share, by device, by value, 2013

FIG. 20 German insulin delivery devices market share, by device, by value, 2013

FIG. 21 French insulin delivery devices market share, by device, by value, 2013

FIG. 22 The U.K. insulin delivery devices market share, by device, by value, 2013

FIG. 23 Italian insulin delivery devices market share, by device, by value, 2013

FIG. 24 Spanish insulin delivery devices market share, by device, by value, 2013

FIG. 25 The Asian insulin delivery devices market share, by country, by value, 2013

FIG. 26 The Asian insulin delivery devices market share, by device, by value, 2013

FIG. 27 Japanese insulin delivery devices market share, by device, by value, 2013

FIG. 28 Chinese insulin delivery devices market share, by device, by value, 2013

FIG. 29 Indian insulin delivery devices market share, by device, by value, 2013

FIG. 30 The Latin American insulin delivery devices market share, by country, by value, 2013

FIG. 31 The Latin American insulin delivery devices market share, by device, by value, 2013

FIG. 32 Brazilian insulin delivery devices market share, by device, by value, 2013

FIG. 33 Market share analysis of insulin delivery devices market, by value, 2013

FIG. 34 Competitive landscape of insulin delivery devices market

FIG. 35 Abbott net sales and net earnings, 2011 - 2013 (USD million)

FIG. 36 Novo Nordisk net sales and net profit, 2011 - 2013 (USD million)

FIG. 37 Lilly revenue and net income, 2011 - 2013 (USD million)

FIG. 38 Medtronic net sales and net earnings, 2011 - 2013 (USD million)

FIG. 39 Sanofi net sales and net profit, 2011 - 2013 (USD million)

FIG. 40 BD revenue and net income, 2011 - 2013 (USD Million)

FIG. 41 Roche Group sales and net income, 2011 - 2013 (USD Million)

FIG. 42 Insulet revenue and net income, 2011 - 2013 (USD Million)

FIG. 43 Ypsomed sales and net profit, 2011 - 2013 (USD Million)

FIG. 44 B. Braun sales and consolidated net profit, 2011 - 2013 (USD Million)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Insulin Delivery Devices Industry, 2016 Market Research Report

Global and Chinese Insulin Delivery Devices Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Insulin Delivery Devices Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Insulin Delivery Devices industry ...

Global Insulin Delivery Systems Market 2016-2020

Global Insulin Delivery Systems Market 2016-2020

  • $ 2500
  • Industry report
  • August 2016
  • by Infiniti Research Limited

About Insulin The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth ...

Needle Free Injection Systems Market by Product, by Technology, Usability, Type of Medication, Delivery Site - Forecasts to 2021

Needle Free Injection Systems Market by Product, by Technology, Usability, Type of Medication, Delivery Site - Forecasts to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 billion by 2021 from USD 9.81 billion in 2016, at a CAGR of 15.5% during the forecast period. The report ...


Download Unlimited Documents from Trusted Public Sources

Topical Delivery Industry in the UK

  • January 2016
    84 pages
  • Topical Deliver...  

    Controlled Rele...  

  • United Kingdom  

    United States  

View report >

Infectious Disease Statistics in Europe - Forecast

  • January 2016
    32 pages
  • Infectious Dise...  

    Nanomedicine  

    Nanotechnology-...  

  • Europe  

View report >

Food Statistics in the US

  • November 2016
    9 pages
  • Food  

  • United States  

    North America  

View report >

Anti-infective Market

23 days ago

Related Market Segments :

Insulin Delivery

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.